These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21208226)

  • 21. Inappropriate ICD discharge due to T-wave oversensing in a patient with short QT syndrome.
    Sun Y; Zhang P; Li X; Guo J
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):113-6. PubMed ID: 19793372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude.
    Baranchuk A; Ribas S; Divakaramenon S; Morillo CA
    Europace; 2007 Aug; 9(8):694-6. PubMed ID: 17478463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An unusual cause of oversensing leading to inappropriate ICD discharges.
    Spencker S; Poppelbaum A; Müller D
    Int J Cardiol; 2008 Sep; 129(1):e24-6. PubMed ID: 17669521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators.
    Wilson DG; Leventigiannis G; Barr C; Morgan JM
    Int J Cardiol; 2016 Oct; 220():27-31. PubMed ID: 27372039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming.
    Lewandowski M; Sterlinski M; Maciag A; Syska P; Kowalik I; Szwed H; Chojnowska L; Przybylski A
    Europace; 2010 Sep; 12(9):1245-50. PubMed ID: 20650939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T wave oversensing in implantable cardioverter defibrillators.
    Hsu SS; Mohib S; Schroeder A; Deger FT
    J Interv Card Electrophysiol; 2004 Aug; 11(1):67-72. PubMed ID: 15273457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish Register of morphology discrimination criterion wavelet (REMEDIO).
    Toquero J; Alzueta J; Mont L; Lozano IF; Barrera A; Berruezo A; Castro V; Peña JL; Fidalgo ML; Brugada J
    Europace; 2009 Jun; 11(6):727-33. PubMed ID: 19411676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inappropriate detection and therapy from an implantable cardioverter defibrillator due to atrial undersensing.
    Paraskevaidis S; Polymeropoulos K; Vassilikos V; Louridas G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):1002-4. PubMed ID: 16176546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of exercise training in patients with an implantable cardioverter defibrillator.
    Vanhees L; Kornaat M; Defoor J; Aufdemkampe G; Schepers D; Stevens A; Van Exel H; Van Den Beld J; Heidbüchel H; Fagard R
    Eur Heart J; 2004 Jul; 25(13):1120-6. PubMed ID: 15231370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.
    Schwab JO; Gasparini M; Lunati M; Proclemer A; Kaup B; Santi E; Ligorio G; Klersy C; DE Sousa J; Okreglicki A; Arenal A; Wijffels M; Lemke B
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):663-6. PubMed ID: 19175450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
    Alexander ME; Cecchin F; Walsh EP; Triedman JK; Bevilacqua LM; Berul CI
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):72-6. PubMed ID: 15028076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting.
    Nishii N; Miyoshi A; Kubo M; Sugiyama H; Tachibana M; Nakagawa K; Watanabe A; Morita H; Ito H
    J Arrhythm; 2017 Apr; 33(2):152-155. PubMed ID: 28416986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy.
    Vollmann D; Lüthje L; Zabel M
    Europace; 2007 May; 9(5):275-7. PubMed ID: 17369268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.